Interferon gamma-1b

TERMINATED · PHASE3 · Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Lung Disease

program discontinued based on GIPF-007 results

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.